Few Benefits, Likely Harms: Against Universal Random Urine Drug Screening in Pain Management

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4637|15|12|2000-2001

ISSN： 1526-2375

Source： PAIN MEDICINE, Vol.15, Iss.12, 2014-12, pp. : 2000-2001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Implications of Urine Drug Testing in Pain Management

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 267-270

Bentham Science Publishers

Access to resources Recommend Favorite

Urine Drug Screening: Necessary or Alienating?

By  

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 1999-1999

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Clinical Impact of a False‐Positive Urine Cocaine Screening Result on a Patient's Pain Management

By  

PAIN MEDICINE, Vol. 16, Iss. 6, 2015-06 ,pp. : 1073-1076

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weighing up the benefits and harms of a new anti‐cancer drug: a survey of Australian oncologists

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 8, 2015-08 ,pp. : 834-842

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urine Drug Screening: Opioid Risks Preclude Complete Patient Autonomy

By  

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 2001-2002

John Wiley & Sons Inc

Access to resources Recommend Favorite